The Latin America, Middle East and Africa Parenteral Nutrition Market would witness market growth of 9% CAGR during the forecast period (2021-2027).
Malnutrition is one of the major driving factors for the development of the parenteral nutrition market. As per the UNICEF, if an infant suffers malnutrition during his first 1,000 days of life could result in impaired cognitive ability and unstable growth. The diet of an infant should have an appropriate balance of vitamins, starch, amino acids, minerals, and lipids. These necessary nutrients can be administered through parenteral nutrition, which is likely to accelerate the growth of the parenteral nutrition market during the forecasting period.
The surge in the occurrences of chronic diseases like cancer positively impacts the adoption of parenteral nutrition across the globe. In addition, parenteral nutrition is extremely beneficial in the administration of essential nutrition that is highly helpful for strength, hydration, and energy level among the patients during their treatment.
The region is witnessing a constant surge in the number of premature infants who are highly vulnerable to stunt growth and catching infections. Therefore, early parenteral nutrition is crucial for preterm infants and must transfer appropriate amino acids & energy. The market players are capitalizing on this opportunity by actively entering the regional market and putting investments in different strategies in order to gain a competitive edge.
High accessibility with ultra-modern supply chain solutions is expected to fuel the growth of the regional parenteral nutrition market in the upcoming years. Moreover, the adoption of parenteral nutrition has been increased in end-user verticals such as diagnostic centers, hospitals, and clinics in order to avoid infections and to maintain hygiene levels. Hence, these factors would open new avenues for growth for the regional parenteral nutrition market.
The Single Dose Amino Acid Solution market dominated the South Africa Parenteral Nutrition Market by Nutrient Type in 2020, thereby, achieving a market value of $54.6 million by 2027. The Parenteral Lipid Emulsion market is estimated to grow at a CAGR of 8.8% during (2021 - 2027). Additionally, The Carbohydrates market is expected to witness highest CAGR of 10.3% during (2021 - 2027).
Based on Nutrient Type, the market is segmented into Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins & Minerals. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Parenteral Nutrition Market is Predict to reach $10.9 Billion by 2027, at a CAGR of 8.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Vifor Pharma Management Ltd., Baxter International, Inc., Allergan PLC (AbbVie), B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Grifols S.A., Pfizer, Inc., ICU Medical, Inc., Anhui Medipharm Co., Ltd. and Aculife Healthcare Private Limited.
By Nutrient Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
